Abstract
The clinical response to sodium cromoglycate treatment was compared with its concentration in serum. Twenty five children with asthma entered a 10 week trial of two baseline weeks followed by eight weeks of treatment by the inhalation of 20 mg of sodium cromoglycate spincaps four times a day. Individual clinical response was determined by the differences between baseline and treatment periods of: (a) percentage of symptomless days (delta score 0); (b) diary derived daily score for four symptoms (delta DS); and (c) peak expiratory flow rate (delta PEFR). At the end of the treatment period, patients inhaled a 20 mg spincap of sodium cromoglycate and the technique of inhalation was graded. Concentrations of sodium cromoglycate in serum were measured by radioimmunoassay in samples withdrawn 5 to 120 minutes after inhalation. Delta Score 0, delta DS, and delta PEFR correlated significantly with the area under the concentration time curve. Both the area under the sodium cromoglycate concentration time curve and clinical response correlated significantly with inhalation technique score. We suggest that response of children with asthma to inhalation treatment with sodium cromoglycate is correlated to its serum concentrations.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berman B. A. Cromolyn: past, present, and future. Pediatr Clin North Am. 1983 Oct;30(5):915–930. doi: 10.1016/s0031-3955(16)34473-x. [DOI] [PubMed] [Google Scholar]
- Bernstein I. L. Cromolyn sodium in the treatment of asthma: coming of age in the United States. J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):381–388. doi: 10.1016/0091-6749(85)90658-x. [DOI] [PubMed] [Google Scholar]
- Brown K., Gardner J. J., Lockley W. J., Preston J. R., Wilkinson D. J. Radioimmunoassay of sodium cromoglycate in human plasma. Ann Clin Biochem. 1983 Jan;20(Pt 1):31–36. doi: 10.1177/000456328302000105. [DOI] [PubMed] [Google Scholar]
- Edmunds A. T., Carswell F., Robinson P., Hughes A. O. Controlled trial of cromoglycate and slow-release aminophylline in perennial childhood asthma. Br Med J. 1980 Sep 27;281(6244):842–842. doi: 10.1136/bmj.281.6244.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuller R. W., Collier J. G. The pharmacokinetic assessment of sodium cromoglycate. J Pharm Pharmacol. 1983 May;35(5):289–292. doi: 10.1111/j.2042-7158.1983.tb02936.x. [DOI] [PubMed] [Google Scholar]
- Furukawa C. T., Shapiro G. G., Bierman C. W., Kraemer M. J., Ward D. J., Pierson W. E. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics. 1984 Oct;74(4):453–459. [PubMed] [Google Scholar]
- Godfrey S., Balfour-Lynn L., König P. The place of cromolyn sodium in the long-term management of childhood asthma based on a 3- to 5-year follow-up. J Pediatr. 1975 Sep;87(3):465–473. doi: 10.1016/s0022-3476(75)80663-9. [DOI] [PubMed] [Google Scholar]
- Levison H., Reilly P. A., Worsley G. H. Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr. 1985 Nov;107(5):662–668. doi: 10.1016/s0022-3476(85)80389-9. [DOI] [PubMed] [Google Scholar]
- Newth C. J., Newth C. V., Turner J. A. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: a double blind study. Aust N Z J Med. 1982 Jun;12(3):232–238. doi: 10.1111/j.1445-5994.1982.tb02467.x. [DOI] [PubMed] [Google Scholar]
- Shapiro G. G., König P. Cromolyn sodium: a review. Pharmacotherapy. 1985 May-Jun;5(3):156–170. doi: 10.1002/j.1875-9114.1985.tb03412.x. [DOI] [PubMed] [Google Scholar]
- Silverman M., Connolly N. M., Balfour-Lynn L., Godfrey S. Long-term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J. 1972 Aug 12;3(5823):378–381. doi: 10.1136/bmj.3.5823.378. [DOI] [PMC free article] [PubMed] [Google Scholar]